Clinical Trial Update: Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary activity of a three-drug combination—pravastatin, idarubicin, and cytarabine—in patients with acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Pravastatin (pravastatin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED